EDNRA and obesity due to melanocortin 4 receptor deficiency: Therefore, therapy with ERAs could potentially be beneficial in obesity to reduce the risk of sequelae such as atherosclerosis, especially in young individuals where ETA-R expression is higher than in older individuals, as shown in our work.